Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $25.00 price objective on the stock. HC Wainwright’s price objective would indicate a potential upside of 264.43% from the […]
Short Interest in Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) Grows By 165 2% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a large growth in short interest in June. As of June 30th, there was short interest totalling 732,800 shares, a growth of 165.2% from the June 15th total of 276,300 shares. Approximately 5.2% of the company’s stock are short sold. Based on an […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 732,800 shares, an increase of 165.2% from the June 15th total of 276,300 shares. Currently, 5.2% of the company’s shares are short sold. […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Longboard Pharmaceuticals in a research report issued to clients and investors on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn ($2.11) per share for the year. The […]